Astera Labs (NASDAQ:ALAB) COO Sanjay Gajendra Sells 94,971 Shares

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) COO Sanjay Gajendra sold 94,971 shares of the company’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the sale, the chief operating officer directly owned 1,531,301 shares of the company’s stock, valued at $189,590,376.81. The trade was a 5.84% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Astera Labs Price Performance

Shares of ALAB traded up $3.04 on Thursday, reaching $132.62. The company’s stock had a trading volume of 2,894,530 shares, compared to its average volume of 5,941,660. The stock’s 50 day simple moving average is $160.78 and its two-hundred day simple moving average is $174.12. The stock has a market capitalization of $22.40 billion, a P/E ratio of 108.70, a PEG ratio of 2.55 and a beta of 1.50. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90.

Astera Labs (NASDAQ:ALABGet Free Report) last released its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.07. The business had revenue of $270.58 million for the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The company’s quarterly revenue was up 91.8% on a year-over-year basis. During the same period last year, the firm earned $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Institutional Trading of Astera Labs

Several hedge funds have recently modified their holdings of the company. Royal Bank of Canada raised its position in Astera Labs by 167.3% during the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after purchasing an additional 95,409 shares during the period. AQR Capital Management LLC raised its holdings in Astera Labs by 213.4% during the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after buying an additional 7,756 shares during the period. Empowered Funds LLC lifted its position in Astera Labs by 917.3% in the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after buying an additional 4,183 shares during the last quarter. CWM LLC boosted its stake in Astera Labs by 79.3% during the second quarter. CWM LLC now owns 6,734 shares of the company’s stock worth $609,000 after buying an additional 2,979 shares during the period. Finally, Harbour Investments Inc. boosted its stake in Astera Labs by 207.7% during the second quarter. Harbour Investments Inc. now owns 2,446 shares of the company’s stock worth $221,000 after buying an additional 1,651 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the company. Northland Securities upped their price target on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 9th. Morgan Stanley reiterated an “overweight” rating and set a $210.00 price objective on shares of Astera Labs in a research note on Wednesday, December 3rd. TD Cowen reissued a “hold” rating on shares of Astera Labs in a report on Wednesday, November 5th. Wall Street Zen lowered Astera Labs from a “buy” rating to a “hold” rating in a research note on Tuesday, November 11th. Finally, Barclays set a $165.00 price target on Astera Labs in a report on Thursday, January 15th. Fourteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $192.89.

Read Our Latest Analysis on Astera Labs

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

See Also

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.